BRASARTAN CTDN

This brand name is authorized in Ecuador

Active ingredients

The drug BRASARTAN CTDN contains a combination of these active pharmaceutical ingredients (APIs):

1 Valsartan UNII 80M03YXJ7I - VALSARTAN

Valsartan is an orally active, potent, and specific angiotensin II (Ang II) receptor antagonist. It acts selectively on the AT1-receptor subtype, which is responsible for the known actions of angiotensin II. Read about Valsartan

2 Chlortalidone UNII Q0MQD1073Q - CHLORTHALIDONE

Chlortalidone is a benzothiadiazine (thiazide)-related diuretic with a long duration of action. Read about Chlortalidone

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C09DA03	Valsartan and diuretics	C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09D Angiotensin II antagonists, combinations → C09DA Angiotensin II antagonists and diuretics
Discover more medicines within C09DA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 2052-MEE-0416, 2404-MEE-0816, 2453-MEE-0916